Reactivación del virus varicela-zóster en dos pacientes inmunodeprimidos

Badiola, Jon; Puerta-Puerta, José Manuel; Muñoz-Medina, Leopoldo; Molina-Leyva, Alejandro.
Med. clín (Ed. impr.) ; 151(2): 87-87, jul. 2018. ilus
Artículo en Español | IBECS (España) | ID: ibc-173785

Documentos relacionados

  1. Varicella-zoster virus-related neurological complications: From infection to immunomodulatory therapies.
  2. Nanopore targeted sequencing-based diagnosis of central nervous system infections in HIV-infected patients.
  3. Viruses, apoptosis, and neuroinflammation--a double-edged sword.
  4. Modulation of Apoptosis and Cell Death Pathways by Varicella-Zoster Virus.
  5. Herpes Zoster Rates Continue to Decline in People Living With Human Immunodeficiency Virus but Remain Higher Than Rates Reported in the General US Population.
  6. Pilot study of antibodies against varicella zoster virus and human immunodeficiency virus in relation to the risk of developing stroke, nested within a rural cohort in Uganda.
  7. Varicella-Zoster Virus-Genetics, Molecular Evolution and Recombination.
  8. Nectin-1 Is an Entry Mediator for Varicella-Zoster Virus Infection of Human Neurons.
  9. Molecular Genetic Insights Into Varicella Zoster Virus (VZV), the vOka Vaccine Strain, and the Pathogenesis of Latency and Reactivation.
  10. Human Embryonic Stem Cell-Derived Neurons Are Highly Permissive for Varicella-Zoster Virus Lytic Infection.